Stock

WINDLAS

Windlas Biotech Limited
Health Technology

Daily Margin Trading Facility book for WINDLAS across NSE and BSE, from 10 Nov 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹31 Cr
as of 10 Sep 2026
Rank in book
#861
208 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹31 Cr
on 10 Sep 2026
Largest single-day addition
+₹2 Cr
on 02 Sep 2026
Largest single-day unwind
−₹1 Cr
on 26 May 2026

NSE & BSE split

How WINDLAS’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹31 Cr · 98.4%BSE ₹0 Cr · 1.6%

MTF vs Price

Margin-funded outstanding for WINDLAS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where WINDLAS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

WINDLAS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 202631+₹00.02%861
09 Sep 202631+₹10.02%864
08 Sep 202630+₹00.02%884
07 Sep 202630+₹00.02%884
04 Sep 202630+₹20.02%879
03 Sep 202628+₹10.02%898
02 Sep 202627+₹20.02%913
01 Sep 202625−₹00.02%947
31 Aug 202626+₹00.02%936
28 Aug 202625+₹00.02%938
27 Aug 202625+₹00.02%948
26 Aug 202625−₹00.02%945
25 Aug 202625−₹00.02%941
24 Aug 202625+₹10.02%938
21 Aug 202625+₹10.02%946
20 Aug 202624−₹00.02%954
19 Aug 202624+₹10.02%950
18 Aug 202623+₹00.02%960
17 Aug 202623−₹10.02%962
14 Aug 202624−₹00.02%950
13 Aug 202624+₹00.02%950
12 Aug 202624−₹10.02%952
11 Aug 202624+₹10.02%940
10 Aug 202623+₹00.02%950
07 Aug 202623+₹00.02%948
06 Aug 202623−₹00.02%950
05 Aug 202623−₹00.02%942
04 Aug 202623+₹00.02%941
03 Aug 202623+₹00.02%934
31 Jul 2026230.02%936

WINDLAS within Health Technology

Ranked #55 of 61 funded Health Technology stocks, carrying 0.5% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
53ASTRAZEN
AstraZeneca Pharma India Limited
₹310.5%
54KPL
Kwality Pharmaceuticals Limited
₹310.5%
55WINDLAS
Windlas Biotech Limited
₹310.5%
56JUBLPHARMA
Jubilant Pharmova Limited
₹310.5%
57FDC
FDC Limited
₹300.5%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.